Is ENDP stock a good buy?
The financial health and growth prospects of ENDP, demonstrate its potential to outperform the market. It currently has a Growth Score of B. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A.
Is Endo Pharmaceuticals a buy?
Endo International has received a consensus rating of Hold. The company’s average rating score is 2.00, and is based on 1 buy rating, 4 hold ratings, and 1 sell rating.
Why is Endo stock dropping?
Shares of Endo International (NASDAQ:ENDP) were crashing 28.6% lower as of 11:07 a.m. EDT on Friday. The big decline came after The Wall Street Journal reported that the drugmaker has engaged Alvarez & Marsal to look into a potential financial restructuring.
Is Endo aesthetics a publicly traded company?
Endo Pharmaceuticals acquired Algos Pharmaceutical Corporation through a merger. As a result of this merger, Endo Pharmaceuticals became a publicly traded company, under the NASDAQ symbol ENDP.
Who owns Endo Pharmaceuticals?
Endo markets its products to primary care physicians and specialists, as well as to other healthcare professionals and retail pharmacies. The company is 60 percent owned by investment firm Kelso & Company.
Is Endo Pharmaceuticals still in business?
Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system….Endo International.
| Type | public liability company |
|---|---|
| Traded as | Nasdaq: ENDP S&P 600 component |
| ISIN | IE00BJ3V9050 |
| Industry | Pharmaceutical |
Who bought Par Pharmaceuticals?
Endo International plc
Endo International plc (NASDAQ: ENDP) (TSX: ENL) and Par Pharmaceutical Holdings, Inc. today announced that they have entered into a definitive agreement under which Endo will acquire privately-held Par from TPG in a transaction valued at $8.05 billion , including assumption of Par debt.
When did Endo buy par?
2015
In 2015, Endo acquired the specialty generics and sterile injectables company Par Pharmaceutical for $8.05 billion.
When did Endo acquire Par Pharmaceuticals?
Endo Completes Acquisition of Par Pharmaceutical and Provides Financial Guidance. DUBLIN , Sept. 28, 2015 /PRNewswire/ — Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced it has completed its previously announced $8.05 billion acquisition of Par Pharmaceutical Holdings, Inc.
Where is Par Pharmaceuticals manufactured?
Rochester, Michigan
With a sterile manufacturing facility located in Rochester, Michigan, Par Sterile Products possesses an unparalleled reputation for high-quality products and an impeccable record of regulatory compliance.
What happened to Par Pharmaceuticals?
Ireland-based Endo International has completed the $8.05bn acquisition of US-based Par Pharmaceutical Holdings from private investment firm TPG Capital North America.
How much do pharmaceutical sales reps make?
Salary. According to the 2016 Pharma Sales Salary Report, the average yearly salary for PSRs in the United States is currently $122,107, with a mean base of $90,862. Specialty pharma reps earn higher salaries at $138,150 on average.
What’s the stock price of Endo International plc?
Endo International plc is currently listed on NASDAQ under ENDP. One share of ENDP stock can currently be purchased for approximately $ 2.83. Is Endo International plc (ENDP) overvalued or undervalued? Endo International plc’s current P/E Non-GAAP (TTM) sector relative grade is A+.
Is the ENDP stock paying a dividend?
ENDP is not currently paying a regular dividend. The total number of shares of a security that have been sold short and not yet repurchased. Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month. Total short positions relative to the number of shares available to trade.
Who are the Institutional Buyers of ENDP stock?
ENDP stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Susquehanna International Group LLP, Mitsubishi UFJ Trust & Banking Corp, California State Teachers Retirement System, Comerica Bank, UBS Asset Management Americas Inc., Arizona State Retirement System, and Simplex Trading LLC.
What does it mean to have restricted stock in ENDP?
Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company’s dividend expressed as a percentage of its current stock price. ENDP is not currently paying a regular dividend. The total number of shares of a security that have been sold short and not yet repurchased.